Abstract
Piper methysticum, kava-kava, awa, kew, tonga (Anonymous, 1996), kawa, yagona, sakau (Norton and Ruze, 1994), ava, ava pepper, intoxicating pepper (Heiligenstein and Guenther, 1998)
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Almedia JC, Grimsley EW. Coma from the health food store: interaction between kava and alprazolam. Ann Intern Med 1996; 125: 940–1.
Anonymous. Kava-kava. In: The review of natural products. St. Louis, MO: Facts and Comparisons, 1996.
Anonymous. Topic of the month. Available from: URL: http://www.ownhealth.com/Topic.html. Accessed 1998 Oct. 29.
Backhauß C, Krieglstein J. Extract of kava (Piper methysticum) and its methysticin constituents protect brain tissue against ischemic damage in rodents. Eur J Pharmacol 1992; 215: 265–9.
Baum SS, Hill R, Rommelspacher H. Effect of kava extract and individual kavapyrones on neurotransmitter levels in the nucleus accumbens of rats. Prog Neuropsychopharmacol Biol Psychiatry 1998; 22: 1105–20.
Blumenthal M. Popular Herbs in the U.S. Market. Kava-kava rhizome. American Botanical Council. Austin, TX, 1997.
Cheng D, Lidgard RO, Duffield PH, Duffield AM, Brophy JJ. Identification by methane chemical ionization gas chromatography/ mass spectrometry of the products obtained by steam distillation and aqueous acid extraction of commercial Piper methysticum. Biomed Environ Mass Spectrom 1988; 17: 371–6.
Davies LP, Drew CA, Duffield P, Johnston GAR, Jamieson DD. Kava pyrones and resin: studies on GABAA, GABAB, and benzodiazepine binding sites in rodent brain. Pharmacol Toxicol 1992; 71: 120–6.
Duffield AM, Jamieson DD, Lidgard RO, Duffield PH, Bourne DJ. Identification of some human urinary metabolites of the intoxicating beverage kava. J Chromatogr 1989; 475: 273–81.
Duffield PH, Jamieson D. Development of tolerance to kava in mice. Clin Exp Pharmacol Physiol 1991; 18: 571–78.
Duffield AM, Lidgard RO. Analysis of kava resin by gas chromatography and electron impact and methane negative ion chemical ionization mass spectrometry. Biomed Environ Mass Spectrometry 1986; 13: 621–6.
Duffield AM, Lidgard RO, Low GKC. Analysis of the constituents of Piper methysticum by gas chromatography methane chemical ionization mass spectrometry. Biomed Environ Mass Spectrometry 1986; 13: 305–13.
Duve RN. Gas—liquid chromatographic determination of major contituents of Piper methysticum. Analyst 1981; 106: 160–5.
Garner LF, Klinger JD. Some visual effects caused by the beverage kava. J Ethnopharamacol 1985; 13: 307–11.
Gleitz J, Beile A, Wilkens P, Ameri A, Peters T. Antithrombotic action of kava pyrone (+)-kavain prepared from Piper methysticum on human platelets. Planta Med 1997; 63: 27–30.
Heiligenstein E, Guenther G. Over-the counter psychotropics: a review of melatonin, St. John’s wort, valerian, and kava-kava. J Am Coll Health 1998; 46: 271–6.
Heinze HJ, Munthe TF, Steitz J, Matzke M. Pharmacopsychological effects of oxazepam and kava-extract in a visual search paradigm assessed with event-related potentials. Pharmacopsychiatry 1994; 27: 224–30.
Jamieson DD, Duffield PH. The antinociceptive actions of kava components in mice. Clin Exp Pharmacol Physiol 1990a; 17: 495–508.
Jamieson DD, Duffield PH. Positive interaction of ethanol and kava resin in mice. Clin Exp Pharmacol Physiol 1990b; 17: 509–14.
Jamieson DD, Duffield PH, Cheng D, Duffield AM. Comparison of the central nervous system activity of the aqueous and lipid extract of kava (Piper methysticum). Arch Int Pharmacodyn 1989; 301: 66–80.
Jappe U, Franke I, Reinhold D, Gollnick HPM. Sebotropic drug interaction resulting from kava-kava extract therapy: a new entity? J Am Acad Dermatol 1998; 38: 104–6.
Jussofie A, Schmiz A, Hiemke C. Kavapyrone enriched extract from Piper methysticum as modulator of the GABA binding site in different regions of rat brain. Psychopharmacology 1994; 116: 469–74.
Keller F, Klohs MW. A review of the chemistry and pharmacology of the constituents of Piper methysticum. Lloydia 1963; 26: 1–15.
Kretzschmar R, Meyer HJ, Teschendorf HJ. Strychnine antagonistic potency of pyrone compounds of the kavaroot (Piper methysticum Forst). Experientia 1970; 26: 283–4.
Locher CP, Burch MT, Mower HF, Berestecky J, Davis H, Van Pool B, et al. Antimicrobial activity and anti-complement activity of extracts obtained from selected Hawaiian medicinal plants. J Ethnopharmacol 1995; 49: 23–32.
Mathews JD, Riley MD, Fejo L, Munoz E, Milns NR, Gardner ID, et al. Effects of the heavy usage of kava on physical health: summary of a pilot survey in an Aboriginal community. Med J Aust 1988; 148: 548–55.
Norton S, Ruze P. Kava dermopathy. J Am Acad Dermatol 1994; 31: 89–97.
Schelosky L, Raffauf C, Jendroska K, Poewe W. Kava and dopamine antagonism. J Neurol Nerosurg Psychiatry 1995; 58: 639–40.
Seitz U, Schule A, Gleitz J. [3H]-Monoamine uptake inhibition properties of kava pyrones. Planta Med 1997; 63: 548–9.
Singh YN. Kava: an overview. J Ethnopharmacol 1992; 37: 13–45.
Singh YN. Effects of kava on neuromuscular transmission and muscle contractility. J Ethnopharmacol 1983; 7: 267–76.
Thorndyke A, Rhyne H. Kava. Available from: URL: http://http://www.unc.edu/-cebradsh/kava.html. Accessed 1998 Oct. 29.
Tyler VE, Brady LR, Robbers JE. Pharamcognosy, 8th edit., Philadelphia: Lea and Febiger, 1981.
Volz HP, Kieser M. Kava-kava extract WS 1490 versus placebo in anxiety disorders-a randomized placebo-controlled 25—week outpatient trial. Pharmacopsychiatry 1997; 30: 1–5.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media New York
About this chapter
Cite this chapter
Reeder, S., Cupp, M.J. (2000). Kava. In: Cupp, M.J. (eds) Toxicology and Clinical Pharmacology of Herbal Products. Forensic Science and Medicine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-020-9_3
Download citation
DOI: https://doi.org/10.1007/978-1-59259-020-9_3
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-190-5
Online ISBN: 978-1-59259-020-9
eBook Packages: Springer Book Archive